China Health Group Balance Sheet Health
Financial Health criteria checks 5/6
China Health Group has a total shareholder equity of HK$59.8M and total debt of HK$5.5M, which brings its debt-to-equity ratio to 9.2%. Its total assets and total liabilities are HK$192.3M and HK$132.6M respectively.
Key information
9.2%
Debt to equity ratio
HK$5.51m
Debt
Interest coverage ratio | n/a |
Cash | HK$8.98m |
Equity | HK$59.75m |
Total liabilities | HK$132.56m |
Total assets | HK$192.32m |
Recent financial health updates
Recent updates
Here's Why China Health Group Limited's (HKG:673) CEO Compensation Is The Least Of Shareholders' Concerns
Sep 05Shareholders Will Probably Not Have Any Issues With China Health Group Limited's (HKG:673) CEO Compensation
Sep 11We Think China Health Group (HKG:673) Has A Fair Chunk Of Debt
Dec 01We Discuss Why China Health Group Limited's (HKG:673) CEO May Deserve A Higher Pay Packet
Sep 23We Think Some Shareholders May Hesitate To Increase China Health Group Limited's (HKG:673) CEO Compensation
Sep 02Did China Health Group Limited (HKG:673) Insiders Sell Shares?
Feb 16Financial Position Analysis
Short Term Liabilities: 673's short term assets (HK$129.0M) exceed its short term liabilities (HK$112.1M).
Long Term Liabilities: 673's short term assets (HK$129.0M) exceed its long term liabilities (HK$20.5M).
Debt to Equity History and Analysis
Debt Level: 673 has more cash than its total debt.
Reducing Debt: 673's debt to equity ratio has increased from 0% to 9.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 673 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 673 is forecast to have sufficient cash runway for 9 months based on free cash flow estimates, but has since raised additional capital.